JOHN FREDERICK DE GROOT to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications JOHN FREDERICK DE GROOT has written about Antineoplastic Agents, Immunological.
Connection Strength
0.256
-
Impact of adverse events of bevacizumab on survival outcomes of patients with recurrent glioblastoma. J Clin Neurosci. 2020 Apr; 74:36-40.
Score: 0.088
-
Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma. Expert Opin Pharmacother. 2019 Sep; 20(13):1609-1624.
Score: 0.085
-
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med. 2019 03; 25(3):477-486.
Score: 0.083